Literature DB >> 2824961

HBV-DNA sequences are rarely detected in the liver of patients with HBsAg-negative chronic active liver disease and with hepatocellular carcinoma in Italy.

P Pontisso1, D Stenico, G Diodati, G Marin, M V Caldironi, R Giacchino, G Realdi, A Alberti.   

Abstract

Hepatitis B virus sequences were studied by molecular hybridization in liver biopsies from patients with HBsAg-negative chronic liver disease or hepatocellular carcinoma, collected in Italy. Among the 42 patients with chronic liver disease who had no history of drug addiction, alcohol abuse nor evidence of metabolic and autoimmune disorders, only two (5%) had HBV-DNA sequences in the liver, although 23 of them (57%) were positive for antibodies to HBV in serum. HBV-DNA was also demonstrated in integrated form in the tumorous tissue of one out of eight cases with HBsAg-negative hepatocellular carcinoma. These incidences of HBV-DNA positivity in the liver are lower than those reported from other Mediterranean areas and similar to those of North Europe, United States and Japan, suggesting that etiologic factors other than HBV are responsible for the majority of HBsAg-negative chronic liver diseases in our region.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824961     DOI: 10.1111/j.1600-0676.1987.tb00345.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  5 in total

Review 1.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

2.  Quantitative detection of hepatitis B virus DNA by real-time nucleic acid sequence-based amplification with molecular beacon detection.

Authors:  S Yates; M Penning; J Goudsmit; I Frantzen; B van de Weijer; D van Strijp; B van Gemen
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 3.  The detection of hepatitis B virus (HBV) in HBsAG negative individuals with primary liver cancer.

Authors:  P Paterlini; C Bréchot
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

4.  Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

5.  Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.

Authors:  Y S White; P J Johnson; F Davison; R Williams
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.